{
    "clinical_study": {
        "@rank": "139463", 
        "arm_group": [
            {
                "arm_group_label": "estradiole  - progesterone   arm", 
                "arm_group_type": "Experimental", 
                "description": "Cases are given estradiole valerate  2mg 3 times /day from day of ovum pick up  until the time of pregnancy test  two weeks together with daily IM injection of  100 progesterone starting  . Single intramuscular 0.1 mg decapeptyl are  given on day of transfer"
            }, 
            {
                "arm_group_label": "Progesterone only arm", 
                "arm_group_type": "Active Comparator", 
                "description": "Patient are given 100 mg progesterone daily starting on day of pickup plus single dose of decapeptyl 0.1 mg on day of embryo transfer"
            }
        ], 
        "brief_summary": {
            "textblock": "Study if supporting luteal phase  of high responder (high egg production or high Estradiol\n      level) long Gn_Rh agonist  protocol ICSI/IVF cycle  by combined Estradiol and progesterone\n      impairs or improves outcome in terms of pregnancy and implanation rates."
        }, 
        "brief_title": "Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "IVF", 
            "Infertility"
        ], 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "The role of estradiol (E2)  luteal support is still debated after more than a decade of use.\n       Two  recent met analyses (Gelbaya et al 2008)   &(Jee et al 2010)(  ) has shown that   the\n      addition of E2 to P4 for  luteal phase support  in IVF/ICSI cycles has no beneficial effect\n      on pregnancy rates. However they commented that  the  data in the literature are, limited\n      and heterogeneous, precluding the extraction of clear and definite conclusions. Previous met\n      analysis ( Pritts and Atwood 2002 ) and an update (Fatemi et al 2007 ) and subsequent\n      randomized trials ( Ghanem et al 2009 , Var et al 2011 ) reported  beneficial effects of\n      adding E2 to luteal P4 support. Recent retrospective studies have shown that high response\n      in terms of excess egg production ( >15 . ) and or high E2 (Chen et al 2007,Kyrou et al\n      2009, Sunkara 2011 ) are detrimental to cycle outcome. This prospective randomized trial\n      aims to study whether adding E2 to P4 luteal support in high ovarian responders is\n      detrimental to cycle outcome or not\n\n      --------------- Gelbaya TA, KyrgiouM, Tsoumpou I, Nardo LG. The use of estradiol for luteal\n      phase support in in vitro fertilization/intracytoplasmic sperminjec- tion cycles: a\n      systematic review and meta-analysis. Fertil Steril 2008;90: 2116-25.\n\n      Jee BC, Suh CS, Kim SH, Kim YB, Moon SY. Effects of estradiol supplementation during the\n      luteal phase of in vitro fertilization cycles: a meta-analysis Fertil Steril. 2010\n      Feb;93(2):428-36\n\n      Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of\n      randomized trials. Hum Reprod 2002;17:2287-99 Fatemi HM, Popovic-Todorovic B, Papanikolaou\n      E, Donoso P,Devroey P. An update of luteal phase support in stimulated IVF cycles.Hum Reprod\n      Update 2007;13:581.\n\n        -  Ghanem M E., Ehab E. Sadek, Elboghdady L. A.. Helal A S, Gamal Anas, Eldiasty A Bakre N\n           I., Houssen M .The effect of luteal phase support protocol on cycle outcome and luteal\n           phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles:\n           a randomized clinical trial , Fertility and Sterility  2009 92: 486-493\n\n      Var T, Tonguc EA, Do\u011fanay M, Gulerman C, Gungor T, Mollamahmutoglu L. A comparison of the\n      effects of three different luteal phase support protocols on in vitro fertilization\n      outcomes: a randomized clinical trial. Fertil Steril. 2011 Mar 1;95(3):985-9.\n\n      van der Gaast, Eijkemans  JB, de Boer  EJ, Burger CW , van Leeuwen FE, Fauser BCJM ,  and\n      Macklon NS Optimum number of oocytes for a successful first IVF treatment cycle\n      Reproductive BioMedicine Online 2006 ; 13:  476-480\n\n      Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A.\n      Association between the number of eggs and live birth in IVF treatment: an analysis of 400\n      135 treatment cycles. Hum Reprod 2011; 26: 1768-1774\n\n      Chen QJ, Sun XX, Li L, Gao XH, Wu Y, Gemzell-Danielsson K, Cheng LN Effects of ovarian high\n      response on implantation and pregnancy outcome during controlled ovarian hyperstimulation\n      (with GnRH agonist and rFSH). Acta Obstet Gynecol Scand. 2007;86:849-54 Kyrou D.,\n      Popovic-Todorovic B., Fatemi H.M1, Bourgain C, Haentjens P., Van Landuyt L., and. Devroey P\n      Does the estradiol level on the day of human chorionic gonadotrophin administration have an\n      impact on pregnancy rates in patients treated  with rec-FSH/GnRH antagonist? Hum Reprod\n      2009,  2902-2909,"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria\n\n          -  age<40 years,\n\n          -  first ICSI cycle,\n\n          -  third day FSH< 10 mIU/mL,\n\n          -  serum E2 level on day of hCG administration <4,000 pg/mL,\n\n          -  number of ova obtained >15\n\n        Exclusion Criteria:\n\n          -  age 40 years or more,\n\n          -  basal FSH 10 mIU/mL or more ,\n\n          -  eggs retrieved  15 or less ,\n\n          -  E2 level on day of hCG administration 4000 or more  pg/ mL or more,\n\n          -  repeat ICSI , need for PGD, presence of myoma , hydrosalpinx (unless disconnected)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "39 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01790282", 
            "org_study_id": "E2 luteal support in  ICSI"
        }, 
        "intervention": [
            {
                "arm_group_label": "estradiole  - progesterone   arm", 
                "description": "estradile valaerate 2mg  plus progesterone 100 mg/day  support arm :E2 valerate 2mg three times /day are given to the arm cases plus P4 100 IM/day for 14 days starting on day of ovum pickup and single IM injection of 0.1 mg decapeptyl on day of ET", 
                "intervention_name": "estradiol  plus progesterone 100 mg IM injection", 
                "intervention_type": "Drug", 
                "other_name": [
                    "estradiole valerate  2mg,", 
                    "Prontogest 100 mg"
                ]
            }, 
            {
                "arm_group_label": [
                    "estradiole  - progesterone   arm", 
                    "Progesterone only arm"
                ], 
                "description": "Starting on day of ovum pickup ICSI cases are given  prontogest 100 mg  IM /day plus single dose  dose of treptorline 0.1mg is given sc  on day of embryo transfer", 
                "intervention_name": "Progesterone    IM of 100 mg", 
                "intervention_type": "Drug", 
                "other_name": "prontogest 100 mg ampoles"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Estradiol", 
                "Progesterone", 
                "Deslorelin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "luteal support", 
            "high responder", 
            "ICSI", 
            "ivf", 
            "cycle outcome"
        ], 
        "lastchanged_date": "February 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mansoura", 
                        "country": "Egypt", 
                        "state": "Dekahlia"
                    }, 
                    "name": "Mansoura Integrated fertility center"
                }
            }, 
            {
                "contact": {
                    "email": "meghanem87@gmail.com", 
                    "last_name": "Mohamad E Ghanem, MD", 
                    "phone": "00201223366955"
                }, 
                "facility": {
                    "address": {
                        "city": "Mansoura", 
                        "country": "Egypt", 
                        "state": "Dekahlia"
                    }, 
                    "name": "Mansoura integrated fertility center"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Is E2 Luteal Support in High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Cycle Outcome ? A Randomized Clinical Trial", 
        "overall_contact": {
            "email": "meghanem87@gmail.com", 
            "last_name": "mohamad E GHanem, MD", 
            "phone": "00201223366955"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "pregnancy rate per started cycle", 
                "measure": "cycle pregnancy rate", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "description": "pregnancy rate per started cycle", 
                "measure": "Cycle pregnancy rate", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }
        ], 
        "reference": [
            {
                "PMID": "18178194", 
                "citation": "Gelbaya TA, Kyrgiou M, Tsoumpou I, Nardo LG. The use of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection cycles: a systematic review and meta-analysis. Fertil Steril. 2008 Dec;90(6):2116-25. Epub 2008 Jan 7. Review."
            }, 
            {
                "PMID": "21558332", 
                "citation": "Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011 Jul;26(7):1768-74. doi: 10.1093/humrep/der106. Epub 2011 May 10."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01790282"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mansoura Integrated Fertility Center", 
            "investigator_full_name": "Mohamad Elsaid Ghanem", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "implantation rate,multible pregnancy rate, abortion rate", 
            "measure": "implantation rate, multiple pregnancy rate, ongoing pregnancy rate ,live birth rate", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "source": "Mansoura Integrated Fertility Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mansoura Integrated Fertility Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}